Zobrazeno 1 - 10
of 1 171
pro vyhledávání: '"Stephen J. Freedland"'
Autor:
Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts
Publikováno v:
BJUI Compass, Vol 5, Iss 11, Pp 1095-1100 (2024)
Abstract Objectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating a
Externí odkaz:
https://doaj.org/article/f57ea34029494f88bb93cf79a944e62a
Autor:
Lourdes Guerrios‐Rivera, Jessica L. Janes, Amanda M. De Hoedt, Zachary Klaassen, Martha K. Terris, Matthew R. Cooperberg, Christopher L. Amling, Christopher J. Kane, William J. Aronson, Jay H. Fowke, Stephen J. Freedland
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background We previously reported that outcomes after radical prostatectomy (RP) were similar among non‐Hispanic Black, non‐Hispanic White, and Hispanic White Veterans Affairs (VA) patients. However, prostate cancer (PC) mortality in Pue
Externí odkaz:
https://doaj.org/article/1f8490175ba24d1daf59e10a3300a60a
Autor:
Paige K. Kuhlmann, Taofik Oyekunle, Zachary Klaassen, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Stephen J. Freedland
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10931-10938 (2023)
Abstract Purpose Limited data exist to help surgeons decide between active surveillance (AS) versus treatment for men with favorable intermediate risk (FIR) prostate cancer. To estimate the theoretical excess risk of prostate cancer‐specific mortal
Externí odkaz:
https://doaj.org/article/4d5fedcbfe114dd68603518ab3bb6be4
Autor:
Gloria Cecilia Galvan, Nadine A. Friedrich, Sanjay Das, James P. Daniels, Sara Pollan, Shweta Dambal, Ryusuke Suzuki, Sergio E. Sanders, Sungyong You, Hisashi Tanaka, Yeon-Joo Lee, Wei Yuan, Johann S. de Bono, Irina Vasilevskaya, Karen E. Knudsen, Michael R. Freeman, Stephen J. Freedland
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionWe previously reported that cholesterol homeostasis in prostate cancer (PC) is regulated by 27-hydroxycholesterol (27HC) and that CYP27A1, the enzyme that converts cholesterol to 27HC, is frequently lost in PCs. We observed that restoring
Externí odkaz:
https://doaj.org/article/ec60d6dd2eac4bd18a56190427b615e9
Autor:
Jian Pan, Jinou Zhao, Xudong Ni, Hualei Gan, Yu Wei, Junlong Wu, Tingwei Zhang, Qifeng Wang, Stephen J. Freedland, Beihe Wang, Shaoli Song, Dingwei Ye, Chang Liu, Yao Zhu
Publikováno v:
Molecular Oncology, Vol 16, Iss 22, Pp 4011-4022 (2022)
The success of the PROfound, IPATential150, and TheraP trials promoted the transition from sequential treatment to therapeutic targets (TTs)‐guided precision treatment in metastatic castration‐resistant prostate cancer (mCRPC). The objective of t
Externí odkaz:
https://doaj.org/article/cd80ca63c001480199b87ae0c3d2bdfd
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1221-1225 (2022)
Background Accumulating evidence suggest that gut microbiota may impact urologic health including prostate cancer (PC), potentially via affecting intestinal permeability (IP). Studies have indicated that disrupted IP may be improved by healthy diets
Externí odkaz:
https://doaj.org/article/efd276261da24cf4bd900ee287bc3aaf
Autor:
Hann‐Hsiang Chao, Payal D. Soni, Bassam Dahman, Spiro C. Stilianoudakis, Hampton Ford, Raj Singh, Stephen J. Freedland, Drew Moghanaki, Neha Vapiwala, Michael G. Chang
Publikováno v:
Cancer Medicine, Vol 11, Iss 15, Pp 2886-2895 (2022)
Abstract Background The optimal upfront treatment modality for patients with nonmetastatic Gleason Score 9 and 10 prostate cancer (GS 9–10 PCa) is unknown. Methods We conducted a retrospective cohort study of patients in the Veterans Health Adminis
Externí odkaz:
https://doaj.org/article/0a7ff5dfc9c54cf9aaf433619ea74a42
Autor:
Andrew R. Cunningham, Lin Gu, Alexandra Dubinskaya, Amanda M. De Hoedt, Kamil E. Barbour, Jayoung Kim, Stephen J. Freedland, Jennifer T. Anger
Publikováno v:
Frontiers in Pain Research, Vol 4 (2023)
ObjectiveTo compare health-related quality of life (HRQOL) and pelvic pain levels over time in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) and those with other pelvic pain conditions (OPPC) including chronic prostatitis, dyspar
Externí odkaz:
https://doaj.org/article/1d0e870e65de491bb6ff1b83d79c9cb7
Autor:
Matthias Neumair, Michael W. Kattan, Stephen J. Freedland, Alexander Haese, Lourdes Guerrios-Rivera, Amanda M. De Hoedt, Michael A. Liss, Robin J. Leach, Stephen A. Boorjian, Matthew R. Cooperberg, Cedric Poyet, Karim Saba, Kathleen Herkommer, Valentin H. Meissner, Andrew J. Vickers, Donna P. Ankerst
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background We compared six commonly used logistic regression methods for accommodating missing risk factor data from multiple heterogeneous cohorts, in which some cohorts do not collect some risk factors at all, and developed an online risk
Externí odkaz:
https://doaj.org/article/41a2d0f14cb04f3b839096814323dacb
Autor:
Kevin H. Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, Bruce J. Trock, Stephen J. Freedland, Michael R. Freeman, Sungyong You, Brandon A. Mahal, Robert B. Den, Adam P. Dicker, R. Jeffrey Karnes, Eric A. Klein, Priti Lal, Yang Liu, Elai Davicioni, Walter Rayford, Kosj Yamoah, Timothy R. Rebbeck
Publikováno v:
European Urology Open Science, Vol 40, Iss , Pp 19-26 (2022)
Background: Socioeconomic and health care utilization factors are major drivers of prostate cancer (PC) mortality disparities in the USA; however, tumor molecular heterogeneity may also contribute to the higher mortality among Black men. Objective: T
Externí odkaz:
https://doaj.org/article/0f6271a5f96f4db29f8e1ec6aede759a